The new buys list of top-performing funds the past three months showed some heavy buying of top-rated stocks. The nation’s leading funds have been stocking up on medical issues, which fared well as the market resumed its uptrend in August. Large heavy-hitting medical stocks being bought by top funds in their latest reporting periods include Gilead Sciences (GILD), Jazz Pharmaceuticals (JAZZ), Allergan (AGN),Celgene (CELG) and Illumina (ILMN).